Cleared Traditional

K983289 - APOLIPOPROTEIN A1
(FDA 510(k) Clearance)

Jan 1999
Decision
133d
Days
Class 2
Risk

K983289 is an FDA 510(k) clearance for the APOLIPOPROTEIN A1. This device is classified as a Alpha-1-lipoprotein, Antigen, Antiserum, Control (Class II - Special Controls, product code DER).

Submitted by Abbott Laboratories (Irving, US). The FDA issued a Cleared decision on January 29, 1999, 133 days after receiving the submission on September 18, 1998.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5580.

Submission Details

510(k) Number K983289 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 18, 1998
Decision Date January 29, 1999
Days to Decision 133 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code DER — Alpha-1-lipoprotein, Antigen, Antiserum, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5580

Similar Devices — DER Alpha-1-lipoprotein, Antigen, Antiserum, Control

All 16
TINA-QUANT APOLIPOPROTEIN VER.2
K013249 · Roche Diagnostics Corp. · Nov 2001
BAYER ADVIA IMS SYSTEM; 200 + 3
K000921 · Bayer Corp. · May 2000
K-ASSAY APO B
K993354 · Kamiya Biomedical Co. · Oct 1999
K-ASSAY APO AI
K993345 · Kamiya Biomedical Co. · Oct 1999
INTEGRA REAGENT CASSETTE FOR APOLIPOPROTEIN A-1
K990594 · Roche Diagnostics Corp. · Apr 1999
N-ASSAY TIA APO A1 TEST KIT
K964292 · Crestat Diagnostics, Inc. · Aug 1997